The firm's Innovance Antithrombin assay is used to monitor antithrombin activity levels in hemophilia patients and aid dosing decisions for a routine prophylaxis.
Last week, readers were most interested in a story about the potentially devastating effects that cuts in US funding for tuberculosis may effect.
The automated DxC 500 I analyzer has a throughput of up to 800 clinical chemistry tests and 100 immunoassays per hour.
NEW YORK — Tasso has struck a deal to offer its blood-collection devices in Japan through a new joint venture with Tokyo-based drug development services provider Shin Nippon Biomedical Laboratories, ...
The firm's next-generation pancreatic cancer test looks for five biomarkers that are indicative of early-stage disease.
The company presented its results this week at a conference and anticipates that with additional validation early next year, it will be ready to file for regulatory approval.
The firm will develop an assay to detect and monitor Pseudomonas aeruginosa infection in patients with cystic fibrosis.
NEW YORK – Invivoscribe announced Thursday that its test for FLT3 mutations in patients with leukemia has achieved regulatory compliance in the UK and Switzerland. The LeukoStrat CDx FLT3 Mutation ...
Proceeds from the offering will be used for research and continued product development, clinical studies, and product commercialization.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果